who were interested in using a single fluorescein conjugate in conjunction with antibodies from different species. The method was further developed and applied to the examination of experimental lesions by Klein and Burkholder (13) ; and subsequently Vogt and Kochem (14) have successfully applied it in human amyloid and Strauss and his colleagues (15) in myasthenia gravis. The principle of the Goldwasser method is to fix guinea pig complement onto tissue sections from other species, using standard serological controls to show that the fixed material is specifically complement. A ttuorescein-conjugated "anti-guinea pig complement" serum is then used to detect the fixed material. The exact specificity of this antiserum is unimportant and equally good results have been obtained (13) with a crude anti-guinea pig globulin serum as with more defined antisera.
The demonstration of in vlvo bound complement represents a totally different problem. Not only is there no control over the conditions under which the complement is fixed, but the complement is of the same species as the rest of the tissue. This leaves the precise antigenic specificity of the "anti-complement" serum as the only factor from which the specificity for complement of the staining can be inferred. Although attempts to make "anti-complement" sera go back for many years, such sera usually contained antibodies against multiple antigens and no firm evidence has been produced that they reacted exclusively with complement components. Such reservations notwithstanding, evidence has been adduced by the use of anti-complement sera for the presence of in ~i~o bound complement in lupus nephritis by Freedman and Markowitz (16) , and in experimental nephritis in the rat by Klein and Burkholder (13) .
Using a fluorescein conjugate of an immunologically pure anti-tim globulin serum, the question of the occurrence of in dvo bound complement and its relation to in vitro complement fixation and to the presence of some other serum components in lesions has been investigated in a number of diseased human tissues. In the present communication the methods and the initial results are presented.
Materials and Methods
Preparation of Sections.--Tissues were obtained at postmortem, within 12 hours of death, or by biopsy. The tissues were cut into suitable size blocks and either frozen at once in a dry ice and acetone mixture, or embedded in gelatin before freezing as described by Burkholder, Littell, and Klein (17) . In either case the frozen blocks were then stored at --20°C.
Sections were cut at a thickness of 4 to 6 microns in a Harris International cryostat, dehydrated, first by air-drying and then in a vacuum desiccator for 30 minutes, and then fixed in acetone for l0 minutes at 4 °. They were then stained immediately or stored at -20 ° for up to 3 days.
Hematoxylin and eosin-stained preparations were obtained for all tissues, either from formalin-fixed tissue taken at the same time, or by fixing sections from the cryostat in formalin. Where indicated, other histological techniques were also used.
Antisera.--All antisera were prepared in rabbits. A predominantly 3"-globulin fraction of the sera was prepared by a single precipitation with 15 per cent sodium sulfate. The precipitated globulins were washed once in 15 per cent sodium sulfate, redissolved in isotonic phosphate buffer, pH 8.0, and then dialyzed against phosphate buffered saline, pH 7.3 (PBS).
Conjugation with fluorescein isothiocyanate (Baltimore Biologicals) was carried out substantially as described by Marshall, Eveland, and Smith (18) . The conjugates were freed from excess fluorescein either by dialysis or by filtration through sephadex (Pharmacia). The latter method gives a very good separation of the conjugate from the free dye and can be completed in a few hours. Before use the conjugates were absorbed with guinea pig liver powder.
All globulin solutions were stored at 4 ° with 1/~000 sodium azide. Estimations of protein concentration [P] were made by the Folin method. The concentration of fluorescein [F] in the conjugates was measured approximately by their optical density of 495 In# and comparison with a standard curve (12) .
The following conjugates have been used:
Anti-fllc-Globulin.--The antiserum was prepared by immunization with pure/31c-globulin (prepared as previously described (11) fig. 2 ). To avoid lowering the antibody titer, the antiserum was not absorbed with 7S ")'-globulin, and a blocking technique was used on the sections to control specificity. in the optical system used these three conjugates gave virtually no background staining and good specific fluorescence. fig. 1 ). This conjugate gave a moderate degree of background staining but its specific fluorescence was very bright. The low antibody activity made it necessary to use the serum at the high protein concentration and consequently high levels of fluorescence. For our optical system this serum was less satisfactory than the others. concentration two to three times that of the conjugate) before adding the conjugate, the section not being washed between the two incubations. In occasional cases three successive additions of unconjugated globulin were made instead of just one before adding the conjugate. A difference of two grades or more in the intensity of fluorescence of the two sections was taken to indicate "specific staining."
Anti-fibrinogen.--The
To demonstrate 19S "y-globulin: To eliminate the reaction with 7S 3'-globulin the test section is pretreated with unconjugated, anti-TS ")'-globulin before adding the anti-19S conjugate The control section was pretreated in the usual way with unconjugated anti-19S 3'-globulin.
Indirect Rheumatoid Factor Staining.-
The test section was treated for 30 minutes at room temperature with diluted serum B containing a uniquely high titer of rheumatoid factor or isolated rheumatoid factor. [t was then washed three times in PBS and stained with anti-19S conjugate. The two sections used in the detection of 19S above acted as controls for this system. Only if bright 7S ~,-globulin staining had been found was blocking of the test section with unconjugated 7S ~, globulin necessary before staining.
The procedure for the model system in Table II was as follows: Substrate was treated with source of antibody for 30 minutes at room temperature, washed three times, and then treated with source of rheumatoid factor for 30 minutes at room temperature. After three further washes the slides were treated for 30 minutes at room temperature with unconjugated anli-7S "y-globulin, and were then stained with the anti-19S conjugate.
To demonstrate in vitro complement fixation: Sections were incubated for 30 minutes at 37 ° with a fresh normal human serum known to be free of rheumatoid factor, immunoconglutinio and antibodies to human tissue antigens demonstrable by complement fixation or immmmfluorescence. The sections were then washed three times in PBS and stained with anti/31c: globulin conjugate. In the experiments using reagents for the detection of comlflement corn ponents these were prepared by standard methods (19, 20) .
Immunoelectrophoresis.--This was carried out according to Seheidegger (33) .
RESULTS

To Show in a Model System That the Fixation of ~ic Detected by [mmunofluorescence is Comparable to Its Behavior in a Hemolytic System.---In a
h e m o l y t i c s y s t e m (10) ~1c r e p r e s e n t s the h y d r a z i n e sensitive m o i e t y of (?':~ (the t h i r d c o m p o n e n t of c o m p l e m e n t ) a n d reacts with the complex E A C ' , m ( a n t i g e n -a n t i b o d y -l l S c o m p o n e n t -f i r s t , f o u r t h , a n d second c o m p l e m e n l comp o n e n t s ) . I t does not react w i t h E A ( a n t i g e n -a n t i b o d y complexes) or a n y of E A C ~ complexes formed before E A C ' 0 m . T h e fixation of ~1c on EAC',14~ occurs best at 37 ° a n d is i n h i b i t e d at 4 °. I t does not require Ca or M g ions.
F o r testing /3~c fixation b y i m m u n o f l u o r e s c e n c e the following s y s t e m was employed. Sections of n o r m a l h u m a n liver were t r e a t e d with a globulin fraction of a lupus serum c o n t a i n i n g high titer c o m p l e m e n t -f i x i n g a n t i b o d i e s to cell nuclei. After washing, t h e sections were t r e a t e d with v a r i o u s c o m p l e m e n t reagents, washed, a n d t h e n s t a i n e d with a n t i ~c conjugate. T a b l e I shows the results o b t a i n e d .
I t c a n be seen t h a t the results c o r r e s p o n d exactly to the b e h a v i o r of ~c in t h e h e m o l y t i c s y s t e m as described above. I n the i m m u n o f l u o r e s c e n t s y s t e m the reagents are used undiluted, and those which are more difficult to prepare satisfactorily (Rus and R1) retained feeble staining although they were satisfactory for use in hemolytic assays. As file-globulin is itself hydrazine-sensitive it is necessary to add it to an R4 before concluding that C', is essential for file fixation. A hemolytically inert C', retained bright staining which was, however, removed by a further absorption with zymosan. Tmmunoelectrophoresis showed that the standard R3 contained a little/~c-globulin, while the reabsorbed reagent contained only the inactivated form fl~A-globulin. An R3 reagent made from guinea pig serum gave, of course, no staining, but on addition of/3~c-globulin bright staining was obtained./~c-globulin on its own gives rise to no staining. In the absence of antibody, the complement reagents did not lead to /3~c fixation on the liver sections. Smears of heat-aggregated "/-globulin, on the other hand, would act alone as substrate for complement fixation. ~1c, once fixed, was not removed by treatment of the section with EDTA, nor by elution with pH 3 buffer for 10 minutes at room temperature. A similar model system was used to show the specificity of the indirect rheumatoid factor staining for antigen-antibody complexes and aggregates. Table II shows the results.
The Demonstration of in Vivo Bound file-Globulin in Tissue Sections.--The tissues examined for the presence of file-globulin and 7S T-globulin are presented in Table III to VI. For convenience the material is presented according to diagnosis. Only specific staining is recorded. Table III shows the results obtained with material from cases of systemic lupus erythematosus. Staining with anti-fllc conjugate was found predominantly in the glomeruli affected by lupus nephritis in which the tufts still persisted. Hyalinized and fibrosed glomeruli showed little staining. The walls of small vessels in the kidney and spleen were also stained. In these sites tim staining ran generally parallel to 7-globulin staining. In anatomically "normal" parts of the tissue file was not found. Most renal casts and the great majority of plasma cells did not stain with antifl-~c globulin. However, in a lupus spleen a small proportion of the plasma cells did stain specifically with ~1c antiserum. The term "plasma cell" in this connection describes a cell of regular oval shape, with a single eccentric nucleus and a non-granular cytoplasm.
TABLE IV
Olc and 7S staining in "nephriHs"
Subacute glomerulonephritis
Subacute glomerulonephritis
Relapsing glomerulonephritis (in remission)
Hypertension
Acute nephritis Table IV shows the results on kidney sections from cases of "nephritis"--using this term widely. Bright file-globulin staining was found in the glomeruli of the two cases of subacute glomerulonephritis and in one of these cases there was some staining of the intima of the afferent arterioles as well. Staining of glomeruli in the three cases of acute glomerulonephritis was less strong but the material here was in no case obtained at the height of the disease. Some staining was found in the glomeruli of the single cases of chronic pyelonephritis, polyarteritis nodosa, and malignant nephrosclerosis. In all these cases, again, the staining occurred only when there were anatomical lesions and it was more or less parallel with the staining of T-globulin. Table V shows the results on 3 cases of amyloid that were studied. One was of primary type and involved the heart predominantly, another was also regarded as primary although spleen and liver were involved. The third case was of secondary type with the main involvement in kidney and liver. All three cases showed bright staining of the amyloid for tim-globulin. In other respects, however, there were differences among the amyloid deposits. In one case of the three the unstained deposits showed a bluish autofluorescence. In this case and one of the other two there was staining with the anti-7S q-globulin serum. In the third case there was no T-globulin staining and it needed three applications of unconjugated antiserum to inhibit the anti-tim staining. This was interpreted as indicating a high concentration of tim at the binding site. This last case was studied further and is discussed again below. Table VI shows the results in a miscellany of other pathological tissues studied. Most of these show no tim staining. However, positive staining was found in the intima of the smaller arteries of several tissues of a patient with WaldenstrSm's macroglobulinemia. These vessels were not obviously abnormal on conventional histology and did not stain with anti-7S ~f-globulin. One of these tissues was studied in greater detail and will be discussed again.
The spleen of a child with idiopathic thrombocytopenic purpura and hemolytic anemia showed staining of the intima of small vessels with both antifile and anti-7ST-globulin. The reticulum around the vessels stained with anti-file .I # and with anti-fibrinogen but not with anti-7S3,-globulin. In this spleen a few "plasma cells" were again seen to stain with anfi-/~m. The heart of a patient dying of acute rheumatic fever showed staining of the intima of vessels in the Aschoff bodies with anti-/~ic. Many small "droplets" stained with both anti-/~m and anti-7S v-globulin. These droplets, which were extracellular, were found to stain with the periodic acid-Schiff reagents after diastase treatment and were palely eosinophilic and difficult to see on the hematoxylin and eosin section. Similar droplets were seen in the septa and alveoli of the lungs of the same patient.
Sections of normal liver, kidney, heart muscle, and skeletal muscle showed no staining with anti-tim and anti-TS "y-globulin. Sections of normal spleen showed plasma cells staining with anti-7S T-globulin, but no cells staining with anti-~m.
More Detailed Study of Selected Tissues.--Many of the sections were studied
by further staining techniques. Table VII summarizes some selected results that bear upon the significance of the tim staining. In a typical case of lupus nephritis (A) the glomeruli stained with anti-/3m-and anti-7S 3"-globulin and to a lesser extent with anti-19S 3,-globulin and anti-fibrinogen. Incubation with fresh human serum did not alter the/3m staining. The indirect rheumatoid factor staining was strongly positive.
Lack of correlation between /3m-and "},-globulin staining was found in renal casts and plasma cells in which staining was obtained only with anti-7-globulin. The plasma cells did not stain with tim after incubation with human complement nor by the indirect rheumatoid factor method. The renal casts on the other hand stained with tim', though by no means always brightly, after incubation with human C'. They, therefore, show some in vitro complement fixation without having complement bound on them in vivo. They stained brightly with the anti-19S serum, so that the rheumatoid factor staining by this technique could not be applied.
Lack of correlation between tim-and 7S ~'-globulin staining was also found in the intimal vessel staining found in most of the organs studied of a case of Waldenstr~Jm's macroglobulinemia and in the amyloid deposits of one of the cases of amyloid. In both of these instances, there was a correlation of staining with anti-fibrinogen. However, in many other instances, there was bright anti-fibrin staining with no file staining. In both the instances quoted there was only feeble staining by the indirect rheumatoid factor method.
Three cases are shown where tim staining became positive only after incubation with human C', i.e. where there was in vitro but not in vivo complement fixation. The most dramatic example was with a lymph node biopsy from a patient (T) with a tentative diagnosis of allergic angiitis. This lymph node showed no staining with either/~m-or 7S T-globulin. However, its whole "reticulum framework" stained very brightly with anti-/~m, but not at all with anti-TS "y-globulin, after incubation with C'. A similar pattern of fluorescence was found when this node was stained by the indirect rheumatoid factor method. With anti-fibrinogen more extensive staining of the structural background of the gland was seen. A similar spectrum of staining was seen with the splenic reticulum of a case of idopathic thrombocytopenic purpura and hemolytic anemia in a child (See Table VI ).
The epithelium of the bile ducts in a case of systemic L.E. and some granules in the hepatic ceils of another case also showed solely in vitro complement staining. The former stained well by the indirect rheumatoid factor method; the latter only feebly. The former failed to stain with the anti-Tglobulin serum; the latter stained feebly.
DISCUSSION
From the evidence of the in vitro complement fixation studies it can be inferred that tim-globulin is fixed on tissue sections under conditions that accurately parallel those of complement fixation and that in sections, just as in a hemolytic system, it is the SAC'0m complex with which it combines. On the basis of these findings, it seems highly likely that the demonstration of ~81o-globulin in an untreated tissue section is indicative of in eivo complement fixation at that site.
From the initial survey of pathological material that has been reported, there seems to be no doubt that in vivo complement fixation does occur at the site of certain lesions and not in normal tissues. Furthermore, analogy with the work of Ross and Lepow (10) on the fixation of complement on antibody-sensitized tissue culture ceils would suggest that such complement fixation represents a true biological complement fixation with cytotoxic sequelae.
However, the exact significance that can be attached to finding complement bound in a tissue requires continued cautious evaluation. Previous studies have tended to assume that even i~ eitro complement binding could be used as evidence for the presence of antigen-antibody complexes at the binding site. In view of the powerful binding of complement to T-globulin aggregates (21) (22) (23) , whether these be made by heating (24) , treatment with mercaptoethanol-urea (25), or with bis-diazobenzidine (23), this assumption is dearly unwarranted. Smears of heat-aggregated T-globulin have served as a substrate to show complement fixation by staining with anti-fllc conjugate and very bright fluorescence was obtained. In fact, the presence of bound complement at a tissue site can be attributed to any of three situations which are known to fix complement:
(a) Antibody bound to antigens normally present at the site. This is the situation studied by Ross and Lepow (10) .
(b) Antigen-antibody complexes unrelated to the tissue site and either bound there by immune adherence (26) or trapped mechanically. This is apparently the situation in serum sickness.
(c) "},-globulin aggregates bound at the site by one mechanism or another. Further, it appears possible that complement may be bound at the sites of immune reactions other than those involving circulating antibodies.
In experimental conditions, immune complexes can be distinguished from T-globulin aggregates by identifying the antigen at the site of the lesion (2); but in human disease where the antigen is either normally present at the lesion site or is unknown, this approach is difficult.
In view of the finding of file staining at sites showing no ~,-globulin staining, the question arises whether in these cases complement is fixed on a substrate other than "r-globulin, or whether ,r-globulin is present and is not stained either because there is too little or because it has lost its antigenicity. Complement is known to be bound on inert particles such as quartz and kaolin, and on non-immune precipitates such as those made with DNA and histone. Since complement preparations free of T-globulin are not available it is not certain whether this binding is always preceded by T-globulin binding. That this is the case, however, is suggested by the observation that such systems, after treatment with a heated serum, are agglutinated by an anti--~-globulin serum (27) .
A further reason for believing that ~,-globulin was present at sites where /3m was fixed is based on the reaction with rheumatoid factor. The specificity of rheumatoid factor for aggregated "y-globulin and antigen-antibody complexes is well established (25, 28 ) and a reaction with rheumatoid factor can be interpreted as showing the presence of 7S ~,-globulin, either aggregated or in an immune complex, at the reaction site. An immunofluorescent method for this purpose was used on much of the material in this study and showed that in all cases where there was/31c bound in vivo, or where it could be bound in vitro, there was at least some reaction with rheumatoid factor. The method shows promise as an alternative to in vitro complement staining for showing antigen-antibody complexes and aggregated ~,-globulin.
In vivo it may well be less important from the standpoint of pathogenicity whether complement is fixed on one substrate or another. Recent evidence clearly indicates that "It-globulin aggregates are biologically active in producing skin reactions (21, 29) . An important factor appears to be whether the site of complement fixation is near enough a cell surface for pharmacologically active agents to be released. Consequently,/3m fixation in vitro in the absence of in vivo binding could be without cytotoxic importance as would ~lc-binding away from cells.
From the material studied the following tentative conclusions could be reached. The glomerular and vascular lesions of systemic L.E. and of "nephritis" showed in vivo complement binding parallel in distribution with ~,-globulin binding, although the relative brightness of the staining with the two reagents varied markedly from case to case. Indirect rheumatoid factor staining also followed the same pattern of distribution. In these diseases immune complexes may reasonably be implicated and the complement binding may well be producing a cytotoxic effect. The finding of in vivo bound complement in the lesions of systemic L.E. and "nephritis" is also consistent with the idea that in vivo complement binding is a factor involved in producing the low serum complement levels often found during the active stage of these diseases (30, 31) .
In contrast, the great majority of plasma cells found in the tissues stained only with anti-7S v-globulin or anti-19S ~,-globulin and thus seem to contain unaggregated ~,-globulin. However, in two tissues a few cells not readily distinguishable from plasma cells, stained with anfi-/31c. In both cases this was found in the spleen and in conditions (systemic L.E. and idiopathic thrombocytopenic purpura with hemolytic anemia) where a high level of complement production could reasonably be expected. It seems possible that these cells are producing the/31c and this would be in accord with the work of Hochwald, Thorbecke, and Asofsky (32) who have shown by a combination of immunoelectrophoreasis and amino acid incorporation studies that 31c-globuiin is formed in spleen and bone marrow.
The renal casts represent structures that are presumably not of immune origin. They showed staining with anti-7S v-globulin and anti-19S as well as by the indirect rheumatoid factor method. Untreated they did not stain with anti-~lc; after incubation with complement they did so to a variable degree. It would therefore appear that they contain some "r-globulin in aggregated form. However, since complement binding was shown only in vitro, this could not be implicated in any tubule damage.
In amyloid the picture was not uniform. In one case there was 31o and no "r-globulin demonstrable and the indirect rheumatoid factor staining was weak. However, in the other two cases 31c-and T-globulin staining was parallel. In all three cases the 31c was fixed in vivo so that it may have played some part in the disease.
In a number of individuals with miscellaneous conditions, results have been obtained whose relevance to the diseases concerned remains incomplete. However, it is of interest that four lesions in this limited survey stained with anti-31c after incubation with serum but not before. It is thus clear that in vivo fixation of C' and the ability to fix C' in vitro cannot be regarded as equivalent.
Why lesions that fix C' in vitro do not do so in vivo is puzzling and a number of possibilities may be considered. It may be that in these cases the C' fixation is an artefact; the treatment of the tissue during freezing and fixation producing the C' binding sites in certain circumstances perhaps in the presence of large amounts of "r-globulin. However, it was not possible to produce C' binding in vitro by freezing and thawing tissue in the presence of "r-globulin. A further cause of artefact could conceivably be the presence of unsuspected tissuereactive antibodies in the C' source. This probably can be excluded since anti-7S "r-globulin failed to stain, for example, the lymph node reticulum (T) after incubation with C'. The possibility that complement was in fact fixed in vivo, but that the 31c-globulin had lost its antigenic determinants, could not be ruled out but it is difficult to see why, even in this case, the binding site should fail to fix 31c in vivo when it can still do so in vitro. Probably an explanation of this effect must await more detailed information as to the conditions governing the in vivo fixation of complement. The reverse question--whether all sites that bind complement in vivo will also fix complement in vitro--has not so far been investigated.
It can be concluded that the detection of in vivo bound complement prorides a further parameter by which the nature of lesions can be studied and that its spectrum is not identical with that provided by the detection of "rglobulin or by in vitro complement fixation. It seems likely that the in vivo complement binding reflects processes at the binding site that, at least in part, are involved in the origin of the lesions there, and thus implicates some immune mechanism in their pathogenesis. SITMMARY A technique has been described for the demonstration of a human complement component by an immunofluorescent method. The component detected is ~ic-globulin, a moiety of the third complement component, which has previously been obtained in pure form and to which a specific antiserum has been prepared.
It has been shown in a model system that the binding of tim-globulin as shown by immunofluorescence is strictly equivalent to complement fixation as assessed by standard serological methods.
This technique has been applied to the detection of in vivo bound complement in pathological human tissues. It was found that in ~vo complement binding occurs in the lesions of several human diseases, but not elsewhere in the same tissues. In a rather limited survey of diseases that has been carried out, in e/w complement binding was found particularly in systemic L.E., various nephritides, and amyloidosis, as well as in single cases of some other diseases.
The spectrum of in ~vo complement binding has been compared with that of ~/-globulin binding (7S and 19S types) and with the demonstration of in ~tro complement fixation and rheumatoid factor fixation. It was distinct from each of these. Rheumatoid factor fixation, detected by anti-19S antiserum showed promise as a method for the detection of antigen-antibody complexes and aggregated y-globulin in tissue sections.
The interpretation of these findings in regard to the nature of the binding sites, and their possible significance in regard to pathogenic mechanisms have been discussed. FIo. 7. Lymph node, allergic angiitis (patient T) stained by indirect rheumatoid actor method to show reticulum staining. X 450.
